Keros Therapeutics, Inc. financial data

Symbol
KROS on Nasdaq
Location
Lexington, MA
Fiscal year end
31 December
Latest financial report
04 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2131% % 0.88%
Debt-to-equity 7.4% % -6.8%
Return On Equity 14% %
Return On Assets 13% %
Operating Margin 28% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 19,717,533 shares -51%
Common Stock, Shares, Outstanding 19,543,706 shares -52%
Entity Public Float $453,000,000 USD -65%
Common Stock, Value, Issued $4,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 37,221,211 shares -0.58%
Weighted Average Number of Shares Outstanding, Diluted 37,859,106 shares 1.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $243,864,000 USD
Revenue from Contract with Customer, Excluding Assessed Tax $246,718,000 USD 37798%
Research and Development Expense $129,643,000 USD -25%
General and Administrative Expense $46,849,000 USD 15%
Operating Income (Loss) $67,569,000 USD 45%
Nonoperating Income (Expense) $24,328,000 USD 2.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $91,897,000 USD 45%
Income Tax Expense (Benefit) $4,883,000 USD 1528%
Net Income (Loss) Attributable to Parent $87,014,000 USD 49%
Earnings Per Share, Basic 2.34 USD/shares 66%
Earnings Per Share, Diluted 2.3 USD/shares 66%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $287,415,000 USD -49%
Accounts Receivable, after Allowance for Credit Loss, Current $3,567,000 USD 30%
Other Assets, Current $2,397,000 USD 65%
Assets, Current $315,434,000 USD -46%
Property, Plant and Equipment, Net $4,297,000 USD 1.4%
Operating Lease, Right-of-Use Asset $16,841,000 USD -13%
Other Assets, Noncurrent $0 USD -100%
Assets $338,021,000 USD -45%
Accounts Payable, Current $1,967,000 USD -57%
Employee-related Liabilities, Current $5,870,000 USD -42%
Accrued Liabilities, Current $16,039,000 USD -23%
Contract with Customer, Liability, Current $155,000 USD
Liabilities, Current $20,414,000 USD -26%
Operating Lease, Liability, Noncurrent $14,475,000 USD -14%
Liabilities $34,889,000 USD -21%
Retained Earnings (Accumulated Deficit) $481,765,000 USD 15%
Stockholders' Equity Attributable to Parent $303,132,000 USD -47%
Liabilities and Equity $338,021,000 USD -45%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $161,171,000 USD
Net Cash Provided by (Used in) Financing Activities $156,802,000 USD 46%
Net Cash Provided by (Used in) Investing Activities $565,000 USD 40%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 40,670,466 shares 0.28%
Common Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $160,610,000 USD 44%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $288,864,000 USD -49%
Deferred Tax Assets, Valuation Allowance $97,991,000 USD -35%
Deferred Tax Assets, Gross $102,840,000 USD -34%
Operating Lease, Liability $16,883,000 USD -10%
Depreciation $344,000 USD 24%
Payments to Acquire Property, Plant, and Equipment $565,000 USD -40%
Lessee, Operating Lease, Liability, to be Paid $21,998,000 USD -15%
Property, Plant and Equipment, Gross $8,732,000 USD 22%
Operating Lease, Liability, Current $2,408,000 USD 22%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,125,000 USD 3.1%
Lessee, Operating Lease, Liability, to be Paid, Year One $4,002,000 USD 5.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.103 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $5,115,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,251,000 USD
Deferred Tax Assets, Operating Loss Carryforwards $35,141,000 USD -22%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $3,100,000 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,983,000 USD
Additional Paid in Capital $1,169,451,000 USD 2.6%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance $4,849,000 USD -6.1%
Share-based Payment Arrangement, Expense $28,696,000 USD -18%
Preferred Stock, Par or Stated Value Per Share 0.0001 USD/shares 0%